Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: Further studies on pain-depressed behavior

Pain

Volumn 144, Issue 1-2, 2009, Pages 170-177

  Pereira Do Carmo, Gail ^a,b   Stevenson, Glenn W ^a,c   Carlezon, William A ^a   Negus, S Stevens ^a,d  

^a MCLEAN HOSPITAL   (United States)

^b MARIST COLLEGE   (United States)

^c UNIVERSITY OF NEW ENGLAND   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Analgesia; Intracranial self stimulation; Morphine; Pain

Indexed keywords

LACTIC ACID; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DRUG EFFECT; ELECTROSTIMULATION; HISTOLOGY; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE; WITHDRAWAL REFLEX;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BIOPHYSICS; CONDITIONING, OPERANT; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; LACTIC ACID; MORPHINE; PAIN; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; SELF STIMULATION;

EID: 67349098173     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2009.04.010     Document Type: Article

References (50)

1. Adams W.J., Lorens S.A., and Mitchell C.L. Morphine enhances lateral hypothalamic self-stimulation in the rat. Proc Soc Exp Biol Med 140 (1972) 770-771
2. Anisman H., and Matheson K. Stress, depression, and anhedonia: caveats concerning animal models. Neurosci Biobehav Rev 29 (2005) 525-546
3. Bair M.J., Robinson R.L., Katon W., and Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med 163 (2003) 2433-2445
4. Bennett G.J. Animal models of pain. In: Kruger L. (Ed). Methods in pain research vol. 4 (2001), CRC Press, Boca Raton, FL 67-91
5. Blackburn-Munro G. Pain-like behaviours in animals - how human are they?. Trends Pharmacol Sci 25 (2004) 299-305
6. Carlezon Jr. W.A., Beguin C., DiNieri J.A., Baumann M.H., Richards M.R., Todtenkopf M.S., Rothman R.B., Ma Z., Lee D.Y., and Cohen B.M. Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther 316 (2006) 440-447
7. Carlezon Jr. W.A., and Chartoff E.H. Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc 2 (2007) 2987-2995
8. Carlezon Jr. W.A., Todtenkopf M.S., McPhie D.L., Pimentel P., Pliakas A.M., Stellar J.R., and Trzcinska M. Repeated exposure to rewarding brain stimulation downregulates GluR1 expression in the ventral tegmental area. Neuropsychopharmacology 25 (2001) 234-241
9. Carlezon Jr. W.A., and Wise R.A. Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801. Brain Res 620 (1993) 339-342
10. Cleeland C.S., and Ryan K.M. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore 23 (1994) 129-138
11. Council National Research. Guide for the Care and Use of Laboratory Animals. Washington DC: National Academy Press; 1996.
12. Cryan J.F., Hoyer D., and Markou A. Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. Biol Psychiatry 54 (2003) 49-58
13. Dworkin R.H., Turk D.C., Wyrwich K.W., Beaton D., Cleeland C.S., Farrar J.T., Haythornthwaite J.A., Jensen M.P., Kerns R.D., Ader D.N., Brandenburg N., Burke L.B., Cella D., Chandler J., Cowan P., Dimitrova R., Dionne R., Hertz S., Jadad A.R., Katz N.P., Kehlet H., Kramer L.D., Manning D.C., McCormick C., McDermott M.P., McQuay H.J., Patel S., Porter L., Quessy S., Rappaport B.A., Rauschkolb C., Revicki D.A., Rothman M., Schmader K.E., Stacey B.R., Stauffer J.W., von Stein T., White R.E., Witter J., and Zavisic S. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 9 (2008) 105-121
14. Easterling K.W., Plovnick R.M., and Holtzman S.G. Acute opioid but not benzodiazepine dependence in rats responding for intracranial self-stimulation. Psychopharmacology (Berl) 148 (2000) 263-271
15. Gallistel C.R., and Freyd G. Quantitative determination of the effects of catecholaminergic agonists and antagonists on the rewarding efficacy of brain stimulation. Pharmacol Biochem Behav 26 (1987) 731-741
16. Grippo A.J., Francis J., Weiss R.M., Felder R.B., and Johnson A.K. Cytokine mediation of experimental heart failure-induced anhedonia. Am J Physiol Regul Integr Comp Physiol 284 (2003) 666-673
17. Gureje O., Von Korff M., Kola L., Demyttenaere K., He Y., Posada-Villa J., Lepine J.P., Angermeyer M.C., Levinson D., de Girolamo G., Iwata N., Karam A., Guimaraes Borges G.L., de Graaf R., Oakley Browne M., Stein D.J., Haro J.M., Bromet E.J., Kessler R.C., and Alonso J. The relation between multiple pains and mental disorders: results from the World Mental Health Surveys. Pain 135 (2008) 82-91
18. Hand T.H., and Franklin K.B. Associative factors in the effects of morphine on self-stimulation. Psychopharmacology (Berl) 88 (1986) 472-479
19. Holtzman S.G. Comparison of the effects of morphine, pentazocine, cyclazocine and amphetamine on intracranial self-stimulation in the rat. Psychopharmacologia 46 (1976) 223-227
20. Hubner C.B., and Kornetsky C. Heroin, 6-acetylmorphine and morphine effects on threshold for rewarding and aversive brain stimulation. J Pharmacol Exp Ther 260 (1992) 562-567
21. Izenwasser S.E., and Kornetsky C. Pharmacological effects of morphine on brain-stimulation reward. Psychopharmacology 93 (1987) 136-137
22. Jann M.W., and Slade J.H. Antidepressant agents for the treatment of chronic pain and depression. Pharmacotherapy 27 (2007) 1571-1587
23. Jha S.H., Knapp C.M., and Kornetsky C. Effects of morphine on brain-stimulation reward thresholds in young and aged rats. Pharmacol Biochem Behav 79 (2004) 483-490
24. Kenny P.J., Chen S.A., Kitamura O., Markou A., and Koob G.F. Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. J Neurosci 26 (2006) 5894-5900
25. Kerns R.D., Turk D.C., and Rudy T.E. The west haven-yale multidimensional pain inventory (WHYMPI). Pain 23 (1985) 345-356
26. Kornetsky C., and Esposito R.U. Euphorigenic drugs: effects on the reward pathways of the brain. Fed Proc 38 (1979) 2473-2476
27. Le Bars D., Gozariu M., and Cadden S.W. Animal models of nociception. Pharmacol Rev 53 (2001) 597-652
28. Lepine J.P., and Briley M. The epidemiology of pain in depression. Hum psychopharmacol 19 (2004) S3-S7
29. Lorens S.A., and Mitchell C.L. Influence of morphine on lateral hypothalamic self-stimulation in the rat. Psychopharmacologia 32 (1973) 271-277
30. Mague S.D., Andersen S.L., and Carlezon Jr. W.A. Early developmental exposure to methylphenidate reduces cocaine-induced potentiation of brain stimulation reward in rats. Biol Psychiatry 57 (2005) 120-125
31. Markou A., and Koob G.F. Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology 4 (1991) 17-26
32. Martin T.J., Buechler N.L., Kahn W., Crews J.C., and Eisenach J.C. Effects of laparotomy on spontaneous exploratory activity and conditioned operant responding in the rat: a model for postoperative pain. Anesthesiology 101 (2004) 191-203
33. Matson D.J., Broom D.C., Carson S.R., Baldassari J., Kehne J., and Cortright D.N. Inflammation-induced reduction of spontaneous activity by adjuvant: a novel model to study the effect of analgesics in rats. J Pharmacol Exp Ther 320 (2007) 194-201
34. Miliaressis E., Rompre P.P., Laviolette P., Philippe L., and Coulombe D. The curve-shift paradigm in self-stimulation. Physiol Behav 37 (1986) 85-91
35. Mogil J.S., and Crager S.E. What should we be measuring in behavioral studies of chronic pain in animals?. Pain 112 (2004) 12-15
36. Morgan D., Carter C.S., Dupree J.P., Yezierski R.P., and Vierck C.J. Evaluation of prescription opioids using operant-based pain measures in rats. Exp Clin Psychopharmacol 16 (2008) 367-375
37. Negus S.S., Vanderah T.W., Brandt M.R., Bilsky E.J., Becerra L., and Borsook D. Preclinical assessment of candidate analgesic drugs: recent advances and future challenges. J Pharmacol Exp Ther 319 (2006) 507-514
38. Pacharinsak C., and Beitz A. Animal models of cancer pain. Comp Med 58 (2008) 220-233
39. Pereira Do Carmo G., Folk J.E., Rice K.C., Chartoff E.H., Carlezon Jr. W.A., and Negus S.S. Effects of the selective delta opioid agonist SNC80 on intracranial self-stimulation in rats: comparison to other pharmacological and non-pharmacological manipulations. Eur J Pharmacol 604 (2009) 58-65
40. Rodriguez L., and Pardo E.G. Reversal by narcotics and narcotic antagonists of pain-induced functional impairment. In: Braude M.C., Harris L.S., May E.L., Smith J.P., and Villarreal J.E. (Eds). Narcotic antagonists (1974), Raven Press, New York 213-223
41. Rodriguez R., and Pardo E.G. Drug reversal of pain induced functional impairment. Arch Int Pharmacodyn Ther 172 (1968) 148-160
42. Roeska K., Doods H., Arndt K., Treede R.D., and Ceci A. Anxiety-like behaviour in rats with mononeuropathy is reduced by the analgesic drugs morphine and gabapentin. Pain 139 (2008) 349-357
43. Schaefer G.J., and Michael R.P. Morphine withdrawal produces differential effects on the rate of lever-pressing for brain self-stimulation in the hypothalamus and midbrain in rats. Pharmacol Biochem Behav 18 (1983) 571-577
44. Seguin L., Le Marouille-Girardon S., and Millan M.J. Antinociceptive profiles of non-peptidergic neurokinin1 and neurokinin2 receptor antagonists: a comparison to other classes of antinociceptive agent. Pain 61 (1995) 325-343
45. Slattery D.A., Markou A., and Cryan J.F. Evaluation of reward processes in an animal model of depression. Psychopharmacology (Berl) 190 (2007) 555-568
46. Stevenson G.W., Bilsky E.J., and Negus S.S. Targeting pain-suppressed behaviors in preclinical assays of pain and analgesia: effects of morphine on acetic acid-suppressed feeding in C57BL/6J mice. J Pain 7 (2006) 408-416
47. Stratmann J.A., and Craft R.M. Intracranial self-stimulation in female and male rats: no sex differences using a rate-independent procedure. Drug Alcohol Depend 46 (1997) 31-40
48. Todtenkopf M.S., Marcus J.F., Portoghese P.S., and Carlezon Jr. W.A. Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. Psychopharmacology (Berl) 172 (2004) 463-470
49. Vierck C.J., Hansson P.T., and Yezierski R.P. Clinical and pre-clinical pain assessment: are we measuring the same thing?. Pain 135 (2008) 7-10
50. Whiteside G.T., Adedoyin A., and Leventhal L. Predictive validity of animal pain models? A comparison of the pharmacokinetic-pharmacodynamic relationship for pain drugs in rats and humans. Neuropharmacology 54 (2008) 767-775